Cl.[NH2:2][N:3]1[CH2:7][C:6](=[O:8])[NH:5][C:4]1=[O:9].[F:10][C:11]1[CH:20]=[C:19]2[C:14]([CH:15]=[CH:16][CH:17]=[N:18]2)=[CH:13][C:12]=1[CH2:21][C:22]1[N:26]2[N:27]=[C:28]([C:31](=O)[CH3:32])[CH:29]=[CH:30][C:25]2=[N:24][CH:23]=1>>[F:10][C:11]1[CH:20]=[C:19]2[C:14]([CH:15]=[CH:16][CH:17]=[N:18]2)=[CH:13][C:12]=1[CH2:21][C:22]1[N:26]2[N:27]=[C:28](/[C:31](=[N:2]/[N:3]3[CH2:7][C:6](=[O:8])[NH:5][C:4]3=[O:9])/[CH3:32])[CH:29]=[CH:30][C:25]2=[N:24][CH:23]=1The title compound was prepared from 1-aminoimidazolidine-2,4-dione hydrochloride and 1-[3-(7-fluoro-quinolin-6-ylmethyl)-imidazo[1,2-b]pyridazin-6-yl]-ethanone in analogy to the synthesis of example 1 in 39% yield. 1H-NMR (400 MHz, DMSO-d6) δ ppm 11.39 (s, 1H), 8.91 (dd, 1H), 8.40 (d, 1H), 8.24 (d, 1H), 8.04 (d, 1H), 7.94 (m, 2H), 7.82 (d, 1H), 7.55 (q, 1H), 4.64 (s, 2H), 4.50 (s, 2H), 2.40 (s, 3H). LCMS (method A): [MH]+=418, tR=4.62 min.